FDA Requests Removal of All Zantac and Ranitidine Medicines
On April 1, 2020, the FDA requested manufacturers of all ranitidine medicines, like Zantac, to remove all medicines from market immediately.
The FDA warned that the medicines may contain NDMA, a contaminant linked to cancer.
Are you concerned about the possible link between Zantac (Ranitidine) and cancer? Take this survey to learn more:
© 2020 Zimmerman Reed LLP. All Rights Reserved. Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome. | CONTACT US | LEGAL NOTICE